Search

everythinglearnresearchcommunity

for

Search:↓

Changes in certain RNA and protein levels may contribute to alopecia areata and could be treatment targets.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Involucrin gene expression is controlled by specific proteins and signaling pathways.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

RANKL improves the immune response against herpes simplex virus by enhancing T cell activation and could help develop better treatments or vaccines.

Nuclear Factor I-C is important for controlling hair growth by affecting the TGF-β1 pathway.

CD80CD86 deficiency causes hair loss by disrupting regulatory T cells.

Abrocitinib may effectively treat Lichen Planopilaris.

Scarring alopecia involves increased immune cells and specific gene changes near damaged hair follicles.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

TRF1 is crucial for creating and maintaining stem cells and marks both pluripotent and adult stem cells.

Phospholipase C-δ1 is crucial for normal hair development.

ICI therapy increases the risk of gastrointestinal and endocrine issues in psoriasis patients.

MLPH helps hair grow by activating IGF-1 signaling in hair cells.

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

SM04755 may be an effective topical treatment for psoriasis.

The choice between belimumab and anifrolumab for treating lupus depends on the patient's specific symptoms.

Understanding how Regulatory T Cells work could help create treatments for certain skin diseases and cancers.

Alopecia areata involves immune system changes, especially in severe cases, with potential new treatment targets identified.

XIST RNA helps regenerate hair follicles by targeting miR-424 and activating hedgehog signaling.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Oleuropein increases IGF-1 levels in mouse skin.

Shrinking of oil glands in the skin is a key sign of hair loss linked to TNF inhibitor drugs and may improve if the treatment is stopped.

The rs231775 genetic variant is linked to a higher risk and severity of Alopecia Areata in males.

Blocking CXCL12 can reverse hair loss and fibrosis in androgenetic alopecia.